Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

Delayed Quote. Delayed  - 02/08 04:02:02 pm
55.8 USD   +2.09%
02/04 WEST PHARMACEUT : expanding Kinston operations
02/03 WEST PHARMACEUT : to Present at LEERINK Conference
01/20 WEST PHARMACEUT : and Noble Collaborate to Improve Patient Education..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 2661 3681 4211 4051 4891 619
Operating income (EBITDA)219248273282322379
Operating profit (EBIT)142162183192222267
Pre-Tax Profit (EBT)109-----
Net income80,711212797,9162197
P/E ratio23,831,230,442,426,221,5
EPS ( $ )1,151,571,751,322,132,60
Dividend per Share ( $ )-0,390,410,470,510,54
Yield-0,79%0,77%0,83%0,91%0,97%
Reference price ( $ )27.37549.0653.2455.855.855.8
Announcement Date02/21/2013
12:15pm
02/20/2014
12:00pm
02/19/2015
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt------
Finance------
Operating income (EBITDA)219248273282322379
Leverage
(Debt/EBITDA)
------
Capital Expenditure---147160150
Book Value Per Share (BVPS)---14,0 $15,5 $17,9 $
Cash Flow per Share-3,09 $2,51 $2,58 $3,37 $3,92 $
Announcement Date02/21/2013
12:15pm
02/20/2014
12:00pm
02/19/2015
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 4 022 M$ -
Entreprise Value (EV) - 4 022 M$
Valuation 2015e 2016e
P/E ratio (Price / EPS) 42,4x 26,2x
Capitalization / Revenue 2,86x 2,70x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) 0,83% 0,91%
Price to book (Price / BVPS) 3,99x 3,61x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 13,7% 14,9%
operating Leverage (Delta EBIT / Delta Sales) - 2,59x
Net Margin (Net Profit / Revenue) 6,97% 10,9%
ROA (Net Profit / Asset) 5,60% 9,20%
ROE (Net Profit / Equities) 11,4% 14,3%
Rate of Dividend 35,4% 23,7%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   10,4% 10,7%
Cash Flow / Sales 13,2% 16,3%
Capital Intensity (Assets / Sales) 1,24x 1,18x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend